Found 196 matching trials
Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants
PHASE1The purpose of this study is to determine whether multiple doses of darunav...
Location
Healthcare Discoveries, Llc D/B/A Icon Development Solutions
Antiviral Agents Against COVID-19 Infection
PHASE2A key strategy in the treatment of COVID-19 would be to find an effective a...
Location
Hospital do Coracao
A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects
PHASE1The purpose of this study is to evaluate the drug-drug interaction of SH229...
Location
Phase I Clinical Trial Unit, The First Hospital of Jilin University
Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy
N/AThe prevalence of HCV infection in Egypt is 14.7%. HCV is both a hepatotrop...
Location
yasmin AbdElazim Mohamed Turkey
Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b
PHASE2The purpose of this study is to confirm that combination of Narlaprevir, Ri...
Location
FBIS CSRI of Epidemiology of Federal Service on Customers
An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject
PHASE2To assess the efficacy and safety profile of co-administration of BMS-79005...
Location
Local Institution
A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir
PHASE1Grps 1, 2, 3 "This study will be testing the performance of ASV and DCV ped...
Location
Multiple Locations
Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults
N/AThe primary objective of the study is to determine the number of adverse ev...
Location
Local Institution
Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual
PHASE3Patients with chronic hepatitis genotype 1b, who are intolerant or ineligib...
Location
Local Institution
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment
PHASE2The purpose of this study is to determine whether BMS-790052 added to Pegin...
Location
Alabama Liver & Digestive Specialists (Alds)